INVO Bioscience ( (INVO) ) has provided an announcement.
INVO Bioscience, Inc. is facing non-compliance with Nasdaq’s minimum bid price rule as its stock price has fallen below $1.00 for 34 consecutive days. While there’s no immediate risk of delisting, the company has until May 17, 2025, to bring its stock price back over $1.00 for at least 10 consecutive business days, or potentially face delisting from the Nasdaq Capital Market. The company is exploring options, such as a reverse stock split, to correct this issue and maintain its listing status.
Learn more about INVO stock on TipRanks’ Stock Analysis page.
